3 Comments
 
Most Helpful

I'm completely pulling all of this out of my butt, but I'll try to be helpful since nobody else has responded. Somebody correct me if I'm mistaken about anything. First off, I don't think they were ever a "big player". IIRC they maxed out at some mid-9-figure AUM but today they're probably sub $100m. I'm guessing most of the AUM today is George's money, but he always seems to be hitting the marketing hard, so maybe they do have some LP $ or are trying to attract more (not sure what the base rate success is for being a reasonably sized fund, facing major redemptions, then making a comeback several years later, but it's probably not good). Distressed may have been a challenged strategy for the 2010s but a major decline in AUM almost always means there was crap performance. They launched a few SPACS in the covid era; one was a now-defunct weed company and I think the other never made it to the transaction stage. Take that as you will. His book is alright, some good stories and a reasonable overview of the investment / portfolio management process. Being a distressed fund with no size and no clout is really tough, though, and at their size today, they likely are not involved in any rx processes like what the book talks about. I think they may have only had a single analyst a couple years ago (linkedin suggests he is no longer there). Again, I don't know this for sure, but it could be good experience if you lack other options but it's likely not a place you can get upward mobility or make any money. 

 

Mollitia nihil porro eligendi et corporis dolor eos. Sunt voluptatem molestiae porro corrupti hic facere. Omnis et praesentium eos.

Dolor eum dolorum quisquam dolores qui. Hic architecto voluptas officiis culpa eos cumque. Quia inventore dolorem aut quod nesciunt aut.

Aliquam ducimus fugiat quia sed. Nisi deserunt aut quia delectus. Et vel molestiae nam occaecati ut eos numquam. Consequatur sit et dolorem quasi deserunt. Ullam ut earum cumque quasi in. Deleniti omnis alias reiciendis atque. Voluptatibus officia recusandae quia quia corrupti.

"If you don't have any enemies in life you have never stood up for anything" - Winston Churchill | "It's a testament to the sheer belligerence of the profession that people would rather argue about the 'risk-adjusted returns' of using inferior tooth cleaning methods." - kellycriterion

Career Advancement Opportunities

September 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.0%
  • Citadel Investment Group 97.0%
  • AQR Capital Management 96.0%
  • Magnetar Capital 95.0%

Overall Employee Satisfaction

September 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • D.E. Shaw 98.0%
  • Blackstone Group 97.0%
  • Citadel Investment Group 96.0%
  • Two Sigma Investments 94.9%

Professional Growth Opportunities

September 2026 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 98.0%
  • D.E. Shaw 97.1%
  • Citadel Investment Group 96.1%
  • Magnetar Capital 95.1%

Total Avg Compensation

September 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (11) $372
  • NA (9) $320
  • Engineer/Quant (83) $287
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $193
  • Analysts (234) $178
  • Intern/Summer Associate (29) $145
  • Junior Trader (5) $102
  • Intern/Summer Analyst (276) $95
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
DrApeman's picture
DrApeman
98.9
9
CompBanker's picture
CompBanker
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”